Key result
Novel NPI combining ANP and BNP predicts ~33% higher major cardiovascular events risk after PCI.
Why the study?
Although the predictive value of both ANP and BNP is well known, the prognostic value of a novel natriuretic peptide index combining both remained to be evaluated.
Does a novel natriuretic peptide index (NPI) improve prognostic prediction of major adverse cardiac events compared to ANP and BNP alone in patients with coronary artery disease after successful PCI?
Cohort (n=849)
No
Does a novel natriuretic peptide index (NPI) improve prognostic prediction of major adverse cardiac events compared to ANP and BNP alone in patients with coronary artery disease after successful PCI?
Answers are grounded in this paper and cite their sources.
A novel natriuretic peptide index combining ANP and BNP provides superior prognostic value for predicting adverse cardiac events after successful PCI compared to either biomarker alone.
BACKGROUND: The predictive value of both atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) is well known. This study evaluated the prognostic value of a novel natriuretic peptide index (NPI) combining ANP and BNP. METHODS AND RESULTS: This study included 849 consecutive patients with coronary artery disease who underwent successful percutaneous coronary intervention (PCI). Patients were followed up clinically for up to 3 years or until the occurrence of major adverse cardiac events (MACE). The primary endpoint was a composite of all-cause death and non-fatal myocardial infarction. The NPI (pg/mL) was defined as √ANP×BNP. MACE occurred in 73 patients (8.6%) during the follow-up period. Receiver operating characteristic curve analysis showed the highest area under the curve for NPI (0.779) compared with ANP and BNP (0.773 and 0.755, respectively). A risk analysis of MACE occurrence adjusted for the multivariable model showed the highest hazard ratio (HR) for NPI (1.33; 95% confidence interval [CI] 1.18-1.51; P<0.001) compared with ANP and BNP (HR 1.25 [95% CI 1.13-1.39] and 1.30 [95% CI 1.13-1.49], respectively; P<0.001). The NPI was a significant independent predictor of MACE, among other clinical parameters, in the multivariable analysis. CONCLUSIONS: Compared with ANP and BNP, the NPI was more effective in predicting future adverse events after PCI.
No takes yet. Share an insight, caveat, or question.
Horikoshi et al. (2022) conducted a cohort in Coronary artery disease (n=849). Natriuretic peptide index (NPI) vs. ANP and BNP was evaluated on Composite of all-cause death and non-fatal myocardial infarction (HR 1.33, 95% CI 1.18-1.51, p=<0.001). A novel natriuretic peptide index (NPI) combining ANP and BNP was a significant independent predictor of major adverse cardiac events after percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: